Coherus Oncology
CHRS----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Coherus Oncology(CHRS) predict that the Revenue is 12.31 M (-69.02%), Miss estimate;the EBIT is -36.15 M (+20.43%), Miss estimate;the EPS is -0.27 (+44.9%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.01B69.02%
0.01B64.22%
-0.00B4.80%
EBITMiss expectations
-0.04B20.43%
-0.03B30.48%
-0.00B10.05%
EPSMiss expectations
-0.2744.90%
-0.217255.67%
-0.052810.77%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 5, 2026
Estimate Revenue20.44 M
Estimate EBIT-30.23 M
Estimate EPS-0.2002
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf